Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
Summary by Globe Newswire
10 Articles
10 Articles
All
Left
7
Center
1
Right

+8 Reposted by 8 other sources
Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of...
Sandoz is expanding its presence in Slovenia. The Basel-based generic drug giant has launched construction of a new biosimilar production center in Brnik, an investment of $440 million.
Coverage Details
Total News Sources10
Leaning Left7Leaning Right0Center1Last UpdatedBias Distribution88% Left
Bias Distribution
- 88% of the sources lean Left
88% Left
L 88%
13%
Factuality
To view factuality data please Upgrade to Premium